The page is the record's research on the issuer — no analyst, no rating, no view. # Vistagen Therapeutics, Inc. (NASDAQ: VTGN) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Vistagen Therapeutics, Inc., listed on NASDAQ under ticker VTGN, with ISIN US92840H4002. The LEI is not on the record, as no GLEIF record with the exact legal name in jurisdiction US-NV was found. The security type is Corporate, the sector is 2834 Pharmaceutical Preparations, and the jurisdiction is United States, Nevada. The segment is not on the record. The listing status is listed, not halted. ## The disclosure read The record holds 65 filings in the twelve months to 2026-11-08, across 39 filing days. Of these, 15 are directors' dealings, 14 are corporate news, 14 are regulatory filings, 8 are results, 8 are director changes, 3 are AGM or EGM filings, and 3 are halt or suspension filings. The median gap between filing days is 6.0 days. The latest filing is dated 2026-10-30 and is of type corporate_news, 9 days before the record date. The NASDAQ median is 52 filings, a median cadence gap of 6.0 days and a median latency of 5.0 days across 4359 issuers. The sector median is 63.0 filings, a median cadence gap of 6.0 days and a median latency of 4.0 days across 526 issuers. ## Auditor The auditor of record is KPMG LLP, located in San Francisco, California. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change events. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted. ## Orderability The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations pages read. The count is 0. ## Open research No openly published research notes were found on the record. The count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for this issuer. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001411685.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/VTGN (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1411685/000162828026043271/vtgn-20260331.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/VTGN (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/VTGN · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp